MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-71 Cr | ₹-65 Cr | ₹-69 Cr | ₹198 Cr | ₹80 Cr |
What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-71 Cr |
| Mar2025 | ₹-65 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹198 Cr |
| Mar2022 | ₹80 Cr |
How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-71 Cr | Negative | |
| Mar2025 | ₹-65 Cr | Negative | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹198 Cr | 148.81 | |
| Mar2022 | ₹80 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,280.3 Cr | 3.2% | -3.1% | 70.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.2% |
-3.1% |
70.4% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses